| Price | $1.44 |
| Year Range | $1.18 – $2.48 |
| Market Cap | $458M |
| Industry | Biotechnology |
What Is Ocugen’s AI Stock Analysis?
Ocugen’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Ocugen’s momentum in near-real time.
Ocugen (OCGN) has an AltIndex AI Score of 45/100, currently a Hold signal. The AI Score distills Ocugen's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Ocugen’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Ocugen — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving OCGN’s AI Score?
Fundamentals
Revenue for the last quarter was $1.5M. This represents a decrease of 2.94% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of 8.38%, suggesting positive year-over-year growth. Net income for the last quarter was $-25M. This represents a decrease of 29.72% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 68.78%, which may be a cause for concern. Ebitda for the last quarter was $-20M. This represents a decrease of 14.76% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 55.36%, which may be a cause for concern.
See Ocugen’s earnings and insider transactions.
Technicals
Today's stock price is $1.44. This is an increase of 5.88% compared to a month ago, indicating a positive short-term trend. Compared to a year ago, there is an increase of 42.57%, suggesting a positive long-term trend. The trend is bullish. The current SMA10 is $1.36, which is higher than the previous SMA10 of $1.35. This indicates a potential upward trend in price movement. The RSI is 70, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Ocugen has an estimated 6 open positions. This number is up by 100% in the last couple of months, indicating a company that looking to grow and expand. Potentially a healthy sign. The business outlook among employees at Ocugen is low (an estimate of only 39% of employees have a positive outlook), a concerning sign. Ocugen has an estimate of 10,000 visitors to their webpage. The number of visitors is down by -38% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Ocugen’s job postings, web traffic and app downloads.
Sentiment & social
Ocugen has 64,000 followers on their Twitter page, with no meaningful increase or decrese in the last couple of months.
Track Ocugen’s market sentiment.
Frequently Asked Questions: Ocugen AI Stock Analysis
Ocugen's AltIndex AI Score is 45/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Ocugen a Hold (45/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Ocugen — company overview, fundamentals, technicals and alternative data, with a recommendation. See the OCGN AI Score or sign up to read the full thesis.
